Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Hereditary Risk for Cancer

  • Chapter
  • First Online:
Fundamentals of Cancer Prevention

  • 1711 Accesses

Abstract

Cancer prevention consists of understanding cancer incidence in populations, identifying appropriate risk factors for specific cancers, stratifying individuals according to these risk factors, and applying effective interventions to individuals (and sometimes populations) according to their risk status. Evaluation of hereditary risk of cancer is a vital component of risk stratification. Appropriate assessment of hereditary genetic risk can lead to significant changes in the clinical management of individuals who are found to have a hereditary cancer syndrome; conversely, it can identify individuals who are not at elevated risk despite having a strong familial history of cancer. Through cancer risk evaluation, with or without genetic testing for hereditary cancer syndromes, individuals with inherited genetic changes associated with increased predisposition of cancer can be identified prior to the development or diagnosis of cancer. Determining that an individual has a strong inherited predisposition to cancer provides an opportunity to intervene with prevention and screening strategies documented to reduce cancer incidence, morbidity, or mortality.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • (1999) Cancer risks in BRCA2 mutation carriers. The Breast Cancer Linkage Consortium. J Natl Cancer Inst 91(15):1310–1316

    Google Scholar 

  • Aarnio M, Sankila R et al (1999) Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 81(2):214–218

    Article  PubMed  CAS  Google Scholar 

  • ACOG (1997) ACOG committee opinion. Breast–ovarian cancer screening. Number 176, October 1996. Committee on Genetics. The American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 56(1):82–83

    Article  Google Scholar 

  • Ad Hoc Committee on Genetic Counseling (1975) Genetic counseling. Am J Hum Genet 27(2):240–242

    Google Scholar 

  • Amos C, Frazier M, McGarrity T (2007) Peutz-Jeghers syndrome. In: GeneReviews. www.genetests.org, University of Washington. Accessed 27 Mar 2008

  • Aretz S et al (2005) High proportion of large genomic STK11 deletions in Peutz Jegers syndrome. Hum Mutat 26:513–519

    Article  PubMed  CAS  Google Scholar 

  • ASCO (2003) American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol 21(12):2397–2406

    Article  Google Scholar 

  • ASHG (1994) Statement of the American Society of Human Genetics on genetic testing for breast and ovarian cancer predisposition. Am J Hum Genet 55(5):i–iv

    Google Scholar 

  • Baker LH (1982) Breast Cancer Detection Demonstration Project: five-year summary report. CA Cancer J Clin 32(4):194–225

    Article  PubMed  CAS  Google Scholar 

  • Bane AL, Beck JC, Bleiweiss I et al (2007) BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays. Am J Surg Pathol 31:121–128

    Article  PubMed  Google Scholar 

  • Barnes-Kedar IM, Plon SE (2002) Counseling the at risk patient in the BRCA1 and BRCA2 era. Obstet Gynecol Clin North Am 29(2):341–366, vii

    Article  PubMed  Google Scholar 

  • Boardman LA, Thibodeau SN et al (1998) Increased risk for cancer in patients with the Peutz-Jeghers syndrome. Ann Intern Med 128(11):896–899

    Article  PubMed  CAS  Google Scholar 

  • Brooks-Wilson AR et al (2004) Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J Med Genet 41:508–517

    Article  PubMed  CAS  Google Scholar 

  • Brownstein MH, Wolf M et al (1978) Cowden’s disease: a cutaneous marker of breast cancer. Cancer 41(6):2393–2398

    Article  PubMed  CAS  Google Scholar 

  • Burke W, Daly M et al (1997) Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. JAMA 277(12):997–1003

    Article  PubMed  CAS  Google Scholar 

  • Burn J, Gerdes AM et al (2011) Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomized clinical trial. Lancet 378:2081–2087

    Article  PubMed  Google Scholar 

  • Burt RW et al (2013) NCCN Clinical practice guidelines in oncology (NCCN Guidelines (R))colorectal cancer creening version 2.2013. © national comprehensive cancer network, Inc. Available at www.nccn.org. Accessed 30 Sep 2013

  • Chompret A, Abel A et al (2001) Sensitivity and predictive value of criteria for p53 germline mutation screening. J Med Genet 38:43–47

    Article  PubMed  CAS  Google Scholar 

  • Claus EB, Risch N et al (1994) Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer 73(3):643–651

    Article  PubMed  CAS  Google Scholar 

  • Couch FJ, Weber BL et al (1996) Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene. Hum Mutat 8(1):8–18

    Article  PubMed  CAS  Google Scholar 

  • Daly MB et al (2013) NCCN clinical practice guidelines in oncology (NCCN guidelines (R)) Genetic/Familial High-Risk Assessment: Breast and Ovarian Version 4.2013. © 2013 National Comprehensive Cancer Network, Inc. Available at www.nccn.org. Accessed 30 Sep 2013

  • Domchek SM, Eisen A et al (2003) Application of breast cancer risk prediction models in clinical practice. J Clin Oncol 21(4):593–601

    Article  PubMed  Google Scholar 

  • Dunlop MG, Farrington SM et al (1997) Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet 6(1):105–110

    Article  PubMed  CAS  Google Scholar 

  • EGAPP Working Group (2009) Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med 11:35–41

    Article  Google Scholar 

  • Eisen A, Lubinski J et al (2008) Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers. J Nat Cancer Inst 100:1361–1367

    Article  PubMed  CAS  Google Scholar 

  • Eng C (2000) Will the real Cowden syndrome please stand up: revised diagnostic criteria. J Med Genet 37(11):828–830

    Article  PubMed  CAS  Google Scholar 

  • Fackenthal JD, Marsh DJ et al (2001) Male breast cancer in Cowden syndrome patients with germline PTEN mutations. J Med Genet 38(3):159–164

    Article  PubMed  CAS  Google Scholar 

  • Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61(5):759–767

    Article  PubMed  CAS  Google Scholar 

  • Fisher B et al (2005) Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 97:1652–1662

    Article  PubMed  CAS  Google Scholar 

  • Ford D, Easton DF et al (1994) Risks of cancer in BRCA1-mutation carriers. Lancet 343(8899):692–695

    Article  PubMed  CAS  Google Scholar 

  • Frank TS, Manley SA et al (1998) Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J Clin Oncol 16(7):2417–2425

    PubMed  CAS  Google Scholar 

  • Franks LM, Teich NM (1997) Introduction to the cellular and molecular biology of cancer. Oxford University Press, London

    Google Scholar 

  • Geller G, Botkin JR et al (1997) Genetic testing for susceptibility to adult-onset cancer. The process and content of informed consent. JAMA 277(18):1467–1474

    Article  PubMed  CAS  Google Scholar 

  • Giardiello FM, Brensinger JD et al (1997) The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med 336(12):823–827

    Article  PubMed  CAS  Google Scholar 

  • Goss PE, Ingle JN et al (2011) Exemestane for breast cancer prevention in postmenopausal women. N Engl J Med 364(25):2381–2391

    Article  PubMed  CAS  Google Scholar 

  • Hall JM, Lee MK et al (1990) Linkage of early-onset familial breast cancer to chromosome-17q21. Science 250(4988):1684–1689

    Article  PubMed  CAS  Google Scholar 

  • Hampel H, Peltomaki P (2000) Hereditary colorectal cancer: risk assessment and management. Clin Genet 58(2):89–97

    Article  PubMed  CAS  Google Scholar 

  • Hartmann LC, Sellers TA et al (1999) Clinical options for women at high risk for breast cancer. Surg Clin North Am 79(5):1189–1206

    Article  PubMed  CAS  Google Scholar 

  • Hemminki A (1999) The molecular basis and clinical aspects of Peutz-Jeghers syndrome. Cell Mol Life Sci 55(5):735–750

    Article  PubMed  CAS  Google Scholar 

  • Hemminki A, Markie D et al (1998) A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 391(6663):184–187

    Article  PubMed  CAS  Google Scholar 

  • Izatt L, Greenman J et al (1999) Identification of germline missense mutations and rare allelic variants in the ATM gene in early-onset breast cancer. Genes Chromosomes Cancer 26(4):286–294

    Article  PubMed  CAS  Google Scholar 

  • Jenkins MA et al (2006) Risk of colorectal cancer in monoallelic and biallelic carriers of MYH mutations: a population based case–family study. Cancer Epidemiol Biomarkers Prev 15(2):312–314

    Article  PubMed  CAS  Google Scholar 

  • Johannesdottir G, Gudmundsson J et al (1996) High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients. Cancer Res 56(16):3663–3665

    PubMed  CAS  Google Scholar 

  • Kempers MJ, Kuiper RP et al (2011) Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study. Lancet Oncol 12:49–55

    Article  PubMed  Google Scholar 

  • King JE, Dozois RR et al (2000) Care of patients and their families with familial adenomatous polyposis. Mayo Clin Proc 75(1):57–67

    Article  PubMed  CAS  Google Scholar 

  • King MC et al (2001) Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP–P1) Breast Cancer Prevention Trial. JAMA 286:2251–2256

    Article  PubMed  CAS  Google Scholar 

  • King MC, Marks JH et al (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302(5645):643–646

    Article  PubMed  CAS  Google Scholar 

  • Knudson AG (1971) Mutation and cancer – statistical study of retinoblastoma. Proc Natl Acad Sci USA 68(4):820–823

    Article  PubMed  Google Scholar 

  • Kohlman W, Gruber SB (2004) Hereditary non-polyposis colon cancer. In: GeneReviews. www.genetests.org. Accessed 10 Nov 2004

  • Kriege M, Brekelmans CT et al (2004) Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351(5):427–437

    Article  PubMed  CAS  Google Scholar 

  • Lerman C, Hughes C et al (2000) Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. Prev Med 31(1):75–80

    Article  PubMed  CAS  Google Scholar 

  • Li FP, Fraumeni JF Jr et al (1988) A cancer family syndrome in twenty-four kindreds. Cancer Res 48:5358–5362

    PubMed  CAS  Google Scholar 

  • Liede A, Karlan BY et al (2004) Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature. J Clin Oncol 22(4):735–742

    Article  PubMed  CAS  Google Scholar 

  • Lynch HT, Lynch JF (1998) Genetics of colonic cancer. Digestion 59(5):481–492

    Article  PubMed  CAS  Google Scholar 

  • Lynch HT, Lynch JF (2000) Hereditary nonpolyposis colorectal cancer. Semin Surg Oncol 18(4):305–313

    Article  PubMed  CAS  Google Scholar 

  • Madalinska JBM et al (2007) Predictors of prophylactic bilateral salpingo-oophorectomy compared with gynecologic screening use in BRCA1/2 mutation carriers. J Clin Oncol 25:301–307

    Article  PubMed  Google Scholar 

  • Malander S, Ridderheim M et al (2004) One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern Sweden. Eur J Cancer 40(3):422–428

    Article  PubMed  CAS  Google Scholar 

  • Meijers-Heijboer H et al (2002) Low-penetrance susceptibility to breast cancer due to CHEK2 1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 31:55–59

    Article  PubMed  CAS  Google Scholar 

  • Miki Y, Swensen J et al (1994) Isolation of BRCA1, the 17q-linked breast and ovarian cancer susceptibility gene. Science 266:61–71

    Article  Google Scholar 

  • Narod SA, Risch H et al (1998) Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group. N Engl J Med 339(7):424–428

    Article  PubMed  CAS  Google Scholar 

  • NCCN Clinical Practice Guidelines in Oncology: Colon Cancer. J Natl Compr Canc Netw 2011;9:1238–1290

    Google Scholar 

  • NCCN Clinical Practice Guidelines in Oncology: Genetic/Familial High-Risk Assessment: Breast and Ovarian. J Natl Compr Canc Netw 2010;8:562–594

    Google Scholar 

  • NCI (1998) Breast cancer risk assessment tool for health care providers. N. C. I. Office of Cancer Communication, Bethesda

    Google Scholar 

  • NCI (2007) Breast cancer risk assessment tool. http://bcra.nci.nih.gov/brc/. Accessed 10 Mar 2008

  • Nelen MR, Padberg GW et al (1996) Localization of the gene for Cowden disease to chromosome 10q22-23. Nat Genet 13(1):114–116

    Article  PubMed  CAS  Google Scholar 

  • Nelson HD, Huffman LH, Fu R, Harris EL, U.S. Preventive Services Task Force (2005) Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence for review for the US Preventive Services Task Force. Ann Intern Med 143:362–379

    Article  PubMed  CAS  Google Scholar 

  • NSGC (2004) National Society of Genetic Counselors home page. www.nsgc.org. Accessed 10 Nov 2004

  • Nussbaum RL, McInnes RR, Willard HF (2001) Thompson and Thompson genetics in medicine. W.B. Saunders Company, Philadelphia

    Google Scholar 

  • Offit K (1997) Clinical cancer genetics: risk counseling and management. Wiley-Liss, New York

    Google Scholar 

  • Parmigiani G, Wang W (2004) BRCAPRO. B. Lab, http://astor.som.jhmi.edu/BayesMendel/brcapro.html. Accessed 10 Nov 2004

  • Parmigiani G, Berry D et al (1998) Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 62(1):145–158

    Article  PubMed  CAS  Google Scholar 

  • Peelen T, vanVliet M et al (1997) A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families. Am J Hum Genet 60(5):1041–1049

    PubMed  CAS  Google Scholar 

  • Peelen T, de Leeuw W et al (2000) Genetic analysis of a breast-ovarian cancer family, with 7 cases of colorectal cancer linked to BRCA1, fails to support a role for BRCA1 in colorectal tumorigenesis. Int J Cancer 88(5):778–782

    Article  PubMed  CAS  Google Scholar 

  • Peltomaki P, Vasen HF (1997) Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Gastroenterology 113(4):1146–1158

    Article  PubMed  CAS  Google Scholar 

  • Pennington KP, Swisher EM (2012) Hereditary ovarian cancer: beyond the usual suspects. Gynecol Oncol 124(2):347–353

    Article  PubMed  CAS  Google Scholar 

  • Peters JA, Stopfer JE (1996) Role of the genetic counselor in familial cancer. Oncology (Huntingt) 10(2):159–166

    CAS  Google Scholar 

  • Petrij-Bosch A, Peelen T et al (1997) BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat Genet 17(3):341–345

    Article  PubMed  CAS  Google Scholar 

  • Rebbeck TR, Friebel T et al (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 22(6):1055–1062

    Article  PubMed  Google Scholar 

  • Rebbeck TR, Friebel T et al (2005) Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 carriers: the PROSE Study Group. J Clin Oncol 23(31):7804–7810

    Article  PubMed  CAS  Google Scholar 

  • Risch HA, McLaughlin JR et al (2001) Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 68(3):700–710

    Article  PubMed  CAS  Google Scholar 

  • Rumilla K, Schowalter KV et al (2011) Frequency of deletions of EPCAM (TACSTD1) in MSH2 associated Lynch syndrome. J Mol Diagn 13:93–99

    Article  PubMed  CAS  Google Scholar 

  • Savitsky K, Sfez S et al (1995) The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum Mol Genet 4(11):2025–2032

    Article  PubMed  CAS  Google Scholar 

  • Schmidt MK et al (2007) Breast cancer survival and tumor characteristics in premenopausal women carrying the CHEK2*1100delC germline mutation. J Clin Oncol 25:64–69

    Article  PubMed  CAS  Google Scholar 

  • Schneider K (2001) Counseling about cancer: strategies for genetic counseling. Wiley-Liss, New York

    Google Scholar 

  • Schrag D, Kuntz KM et al (1997) Decision analysis – effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. N Engl J Med 336(20):1465–1471

    Article  PubMed  CAS  Google Scholar 

  • Shattuck-Eidens D, Oliphant A et al (1997) BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing. JAMA 278(15):1242–1250

    Article  PubMed  CAS  Google Scholar 

  • Smith A et al (2007) Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening. J Med Genet 44:10–15

    Article  PubMed  CAS  Google Scholar 

  • Solomon C, Burt RW (2004) Familial adenomatous polyposis. In: GeneReviews. www.genetests.org, University of Washington. Accessed 2 Apr 2004

  • Struewing JP, Hartge P et al (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336(20):1401–1408

    Article  PubMed  CAS  Google Scholar 

  • Swift M, Morrell D et al (1991) Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 325(26):1831–1836

    Article  PubMed  CAS  Google Scholar 

  • Thompson D, Easton D et al (2001) Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. Am J Hum Genet 68(2):410–419

    Article  PubMed  CAS  Google Scholar 

  • Thull DL, Vogel VG (2004) Recognition and management of hereditary breast cancer syndromes. Oncologist 9(1):13–24

    Article  PubMed  Google Scholar 

  • Tinat J, Bouregard G et al (2009) 2009 version of the Chompret criteria for Li Fraumeni syndrome. J Clin Oncol 27:e108–e109

    Article  PubMed  Google Scholar 

  • Tirkkonen M, Johannsson O et al (1997) Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations. Cancer Res 57(7):1222–1227

    PubMed  CAS  Google Scholar 

  • Tonin P, Weber B et al (1996) Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat Med 2(11):1179–1183

    Article  PubMed  CAS  Google Scholar 

  • Tonin PN et al (1998) Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families. Am J Hum Genet 63(5):1341–1351

    Article  PubMed  CAS  Google Scholar 

  • Turner NC, Reis-Filho JS (2006) Basal-like breast cancer and the BRCA1 phenotype. Oncogene 25:5846–5853

    Article  PubMed  CAS  Google Scholar 

  • Tyrer J, Duffy SW, Cuzick J (2004) A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 23(7):1111–1130

    Article  PubMed  Google Scholar 

  • Umar A, Boland CR et al (2004) Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96(4):261–268

    Article  PubMed  CAS  Google Scholar 

  • Vasen HF, van Ballegooijen M et al (1998) A cost-effectiveness analysis of colorectal screening of hereditary nonpolyposis colorectal carcinoma gene carriers. Cancer 82(9):1632–1637

    Article  PubMed  CAS  Google Scholar 

  • Vogel VG, Costantino JP et al (2006) Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA 295(23):2727–2741

    Article  PubMed  CAS  Google Scholar 

  • Walsh T et al (2006) Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA 295:1379–1388

    Article  PubMed  CAS  Google Scholar 

  • Warner E, Plewes DB et al (2004) Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292(11):1317–1325

    Article  PubMed  CAS  Google Scholar 

  • Watanabe T, Wu TT et al (2001) Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med 344(16):1196–1206

    Article  PubMed  CAS  Google Scholar 

  • Weber T (1996) Clinical surveillance recommendations adopted for HNPCC. Lancet 348:465

    Article  Google Scholar 

  • Weischer M, Bojesen SE, Tybjaerg-Hansen A, Axelsson CK, Nordestgaard BG (2007) Increased risk of breast cancer associated with CHEK2*1100delC germline mutation. J Clin Oncol 25:64–69

    Google Scholar 

  • Wijnen JT, Vasen HF et al (1998) Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. N Engl J Med 339(8):511–518

    Article  PubMed  CAS  Google Scholar 

  • Wooster R, Bignell G et al (1995) Identification of the breast-cancer susceptibility gene BRCA2. Nature 378(6559):789–792

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology-Oncology, Mayo Clinic-Scottsdale, Scottsdale, AZ, 85259, USA

    Katherine S. Hunt

  2. Department of Medicine, Division of Hematology-Oncology, University of Arizona Cancer Center, Tucson, AZ, 85724, USA

    Jessica A. Ray & Joanne M. Jeter

Authors
  1. Katherine S. Hunt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jessica A. Ray
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Joanne M. Jeter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joanne M. Jeter .

Editor information

Editors and Affiliations

  1. Arizona Cancer Center, University of Arizona College of Medicine, Tucson, Arizona, USA

    David Alberts

  2. Department of Obstetrics and Gynecology, Indiana University Schools of Medicine and Public Health, Indianapolis, Arizona, USA

    Lisa M. Hess

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Hunt, K.S., Ray, J.A., Jeter, J.M. (2014). Hereditary Risk for Cancer. In: Alberts, D., Hess, L. (eds) Fundamentals of Cancer Prevention. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-38983-2_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-38983-2_5

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-38982-5

  • Online ISBN: 978-3-642-38983-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation